Journal
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
Volume 37, Issue 6, Pages 535-542Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10799893.2017.1365902
Keywords
Diabetic nephropathy; high glucose level; HGF; met receptor; fibronectin; integrin alpha 5 beta 1
Categories
Funding
- European Association for the Study of Diabetes: EFSD New Horizons
Ask authors/readers for more resources
Context: The role of hepatocyte growth factor (HGF) in diabetic kidney damage remains controversial. Objective: To test the hypothesis that high glucose levels activate pathways related to HGF and its receptor Met and that this could participate in glucose-induced renal cell damage. Materials and methods: HK2 cells, a human proximal tubule epithelial cell line, were stimulated with high glucose for 48hours. Levels of pMet/Met, pEGFR/EGFR, pSTAT3/STAT3, pAkt/Akt and pERK1/2/ERK1/2 were studied by immunoblotting. Absence of HGF was verified by qRT-PCR and ELISA. Results: High glucose level activated Met and its downstream pathways STAT3, Akt and ERK independently of HGF. High glucose induced an integrin ligand fibronectin. HGF-independent Met phosphorylation was prevented by inhibition of integrin alpha 5 beta 1, Met inhibitor crizotinib, Src inhibitors PP2 and SU5565, but not by EGFR inhibitor AG1478. High glucose increased the expression of TGF beta-1, CTGF and the tubular damage marker KIM-1 and increased apoptosis of HK2 cells, effects inhibited by crizotinib. Conclusion: High glucose activated Met receptor in HK2 cells independently of HGF, via induction of integrin 51 and downstream signaling. This mode of Met activation was associated with tubular cell damage and apoptosis and it may represent a novel pathogenic mechanism and a treatment target in diabetic nephropathy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available